Immunotherapy combo may outperform chemo in rare lymphoma
Disease control
Not yet recruiting
This Phase 3 trial tests whether an immunotherapy-based regimen (sintilimab, pegaspargase, and anlotinib) works better than standard chemotherapy before a stem cell transplant in people with newly diagnosed, advanced extranodal NK/T-cell lymphoma. Participants are randomly assign…
Phase: PHASE3 • Sponsor: Rong Tao • Aim: Disease control
Last updated Jul 02, 2026 06:00 UTC